Report cover image

Global Period Cramp Pain Killer Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 199 Pages
SKU # APRC20360507

Description

Summary

According to APO Research, the global Period Cramp Pain Killer market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Period Cramp Pain Killer is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Period Cramp Pain Killer is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Period Cramp Pain Killer market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Period Cramp Pain Killer is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Period Cramp Pain Killer market include SK&F, Johnson & Johnson, Bayer, Zambon, SSP CO, Sato Pharmaceutical, Lion Corporation, Kowa Company and GSK Group, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Period Cramp Pain Killer, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Period Cramp Pain Killer, also provides the value of main regions and countries. Of the upcoming market potential for Period Cramp Pain Killer, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Period Cramp Pain Killer revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Period Cramp Pain Killer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Period Cramp Pain Killer company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Period Cramp Pain Killer Segment by Company

SK&F
Johnson & Johnson
Bayer
Zambon
SSP CO
Sato Pharmaceutical
Lion Corporation
Kowa Company
GSK Group
Daewoong
Arax Co
Period Cramp Pain Killer Segment by Type

NSAID
Acetaminophen
Period Cramp Pain Killer Segment by Application

Teenagers
Adults
Period Cramp Pain Killer Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Period Cramp Pain Killer status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Period Cramp Pain Killer key companies, revenue, market share, and recent developments.
3. To split the Period Cramp Pain Killer breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Period Cramp Pain Killer market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Period Cramp Pain Killer significant trends, drivers, influence factors in global and regions.
6. To analyze Period Cramp Pain Killer competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Period Cramp Pain Killer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Period Cramp Pain Killer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Period Cramp Pain Killer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Period Cramp Pain Killer industry.
Chapter 3: Detailed analysis of Period Cramp Pain Killer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Period Cramp Pain Killer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Period Cramp Pain Killer in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Period Cramp Pain Killer Market Size, 2020 VS 2024 VS 2031
1.3 Global Period Cramp Pain Killer Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Period Cramp Pain Killer Market Dynamics
2.1 Period Cramp Pain Killer Industry Trends
2.2 Period Cramp Pain Killer Industry Drivers
2.3 Period Cramp Pain Killer Industry Opportunities and Challenges
2.4 Period Cramp Pain Killer Industry Restraints
3 Period Cramp Pain Killer Market by Company
3.1 Global Period Cramp Pain Killer Company Revenue Ranking in 2024
3.2 Global Period Cramp Pain Killer Revenue by Company (2020-2025)
3.3 Global Period Cramp Pain Killer Company Ranking (2023-2025)
3.4 Global Period Cramp Pain Killer Company Manufacturing Base and Headquarters
3.5 Global Period Cramp Pain Killer Company Product Type and Application
3.6 Global Period Cramp Pain Killer Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Period Cramp Pain Killer Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Period Cramp Pain Killer Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Period Cramp Pain Killer Market by Type
4.1 Period Cramp Pain Killer Type Introduction
4.1.1 NSAID
4.1.2 Acetaminophen
4.2 Global Period Cramp Pain Killer Sales Value by Type
4.2.1 Global Period Cramp Pain Killer Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Period Cramp Pain Killer Sales Value by Type (2020-2031)
4.2.3 Global Period Cramp Pain Killer Sales Value Share by Type (2020-2031)
5 Period Cramp Pain Killer Market by Application
5.1 Period Cramp Pain Killer Application Introduction
5.1.1 Teenagers
5.1.2 Adults
5.2 Global Period Cramp Pain Killer Sales Value by Application
5.2.1 Global Period Cramp Pain Killer Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Period Cramp Pain Killer Sales Value by Application (2020-2031)
5.2.3 Global Period Cramp Pain Killer Sales Value Share by Application (2020-2031)
6 Period Cramp Pain Killer Regional Value Analysis
6.1 Global Period Cramp Pain Killer Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Period Cramp Pain Killer Sales Value by Region (2020-2031)
6.2.1 Global Period Cramp Pain Killer Sales Value by Region: 2020-2025
6.2.2 Global Period Cramp Pain Killer Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Period Cramp Pain Killer Sales Value (2020-2031)
6.3.2 North America Period Cramp Pain Killer Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Period Cramp Pain Killer Sales Value (2020-2031)
6.4.2 Europe Period Cramp Pain Killer Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Period Cramp Pain Killer Sales Value (2020-2031)
6.5.2 Asia-Pacific Period Cramp Pain Killer Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Period Cramp Pain Killer Sales Value (2020-2031)
6.6.2 South America Period Cramp Pain Killer Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Period Cramp Pain Killer Sales Value (2020-2031)
6.7.2 Middle East & Africa Period Cramp Pain Killer Sales Value Share by Country, 2024 VS 2031
7 Period Cramp Pain Killer Country-level Value Analysis
7.1 Global Period Cramp Pain Killer Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Period Cramp Pain Killer Sales Value by Country (2020-2031)
7.2.1 Global Period Cramp Pain Killer Sales Value by Country (2020-2025)
7.2.2 Global Period Cramp Pain Killer Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.3.2 USA Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.4.2 Canada Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.6.2 Germany Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.7.2 France Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.7.3 France Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.9.2 Italy Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.10.2 Spain Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.11.2 Russia Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.14.2 China Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.14.3 China Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.15.2 Japan Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.17.2 India Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.17.3 India Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.18.2 Australia Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.22.2 Chile Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.24.2 Peru Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.26.2 Israel Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.27.2 UAE Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.29.2 Iran Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Period Cramp Pain Killer Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Period Cramp Pain Killer Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Period Cramp Pain Killer Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 SK&F
8.1.1 SK&F Comapny Information
8.1.2 SK&F Business Overview
8.1.3 SK&F Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.1.4 SK&F Period Cramp Pain Killer Product Portfolio
8.1.5 SK&F Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Period Cramp Pain Killer Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Bayer
8.3.1 Bayer Comapny Information
8.3.2 Bayer Business Overview
8.3.3 Bayer Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.3.4 Bayer Period Cramp Pain Killer Product Portfolio
8.3.5 Bayer Recent Developments
8.4 Zambon
8.4.1 Zambon Comapny Information
8.4.2 Zambon Business Overview
8.4.3 Zambon Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.4.4 Zambon Period Cramp Pain Killer Product Portfolio
8.4.5 Zambon Recent Developments
8.5 SSP CO
8.5.1 SSP CO Comapny Information
8.5.2 SSP CO Business Overview
8.5.3 SSP CO Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.5.4 SSP CO Period Cramp Pain Killer Product Portfolio
8.5.5 SSP CO Recent Developments
8.6 Sato Pharmaceutical
8.6.1 Sato Pharmaceutical Comapny Information
8.6.2 Sato Pharmaceutical Business Overview
8.6.3 Sato Pharmaceutical Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.6.4 Sato Pharmaceutical Period Cramp Pain Killer Product Portfolio
8.6.5 Sato Pharmaceutical Recent Developments
8.7 Lion Corporation
8.7.1 Lion Corporation Comapny Information
8.7.2 Lion Corporation Business Overview
8.7.3 Lion Corporation Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.7.4 Lion Corporation Period Cramp Pain Killer Product Portfolio
8.7.5 Lion Corporation Recent Developments
8.8 Kowa Company
8.8.1 Kowa Company Comapny Information
8.8.2 Kowa Company Business Overview
8.8.3 Kowa Company Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.8.4 Kowa Company Period Cramp Pain Killer Product Portfolio
8.8.5 Kowa Company Recent Developments
8.9 GSK Group
8.9.1 GSK Group Comapny Information
8.9.2 GSK Group Business Overview
8.9.3 GSK Group Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.9.4 GSK Group Period Cramp Pain Killer Product Portfolio
8.9.5 GSK Group Recent Developments
8.10 Daewoong
8.10.1 Daewoong Comapny Information
8.10.2 Daewoong Business Overview
8.10.3 Daewoong Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.10.4 Daewoong Period Cramp Pain Killer Product Portfolio
8.10.5 Daewoong Recent Developments
8.11 Arax Co
8.11.1 Arax Co Comapny Information
8.11.2 Arax Co Business Overview
8.11.3 Arax Co Period Cramp Pain Killer Revenue and Gross Margin (2020-2025)
8.11.4 Arax Co Period Cramp Pain Killer Product Portfolio
8.11.5 Arax Co Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.